BioSpace News Archive

Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces James Romero as the company’s President, Americas

Shimmer Research, a global leader in wearable technology for research applications, today announced that Boston University (BU) School of Medicine has selected Shimmer’s Verisense® wearable sensing platform to monitor participants’ motion, activity, and sleep in two brain health studies funded by the American Heart Association in collaboration with global philanthropist Bill Gates.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced collaborations with nationwide medical organizations in the Netherlands and Japan to raise awareness of the eNRGy trial and to provide molecular screening opportunities for patients with cancers that may have neuregulin 1 fusions.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that non-invasive genomic patch testing for melanoma, like DermTech’s Pigmented Lesion Assay (“PLA”), has received a recommendation from the National Comprehensive Cancer Network® (“NCCN”).

Arcus Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted three new employees options to purchase a total of 31,600 shares of the Company’s common stock at an exercise price per share of $30.83, which was the closing price on January 8, 2021.

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Health Care Conference on Thursday, January 14, at 5:20 PM ET

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TMB-003, the company’s locally delivered formulation of sitaxsentan,

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced their participation at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021.

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock.

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, appointed Dr. Joachim Hasenmaier, the former head of Boehringer Ingelheim Animal Health, to the Company’s Board of Directors, effective January 11, 2021.